Effects of Energy and Physical Density Manipulation on Appetite

As individuals tend to eat a constant weight or volume of food, manipulating physical and energy densities generally results in changes in energy intake without affecting subjective appetite sensations. However, relatively few studies have directly studied the interaction between physical and energy density manipulation. This study will determine the effects of foods that systematically vary in physical and energy density on ad libitum energy intake and subjective appetite ratings. Secondary outcomes will include gastrointestinal discomfort, fatigue and acceptability.

Study Overview

Detailed Description

A historical challenge for military personnel operating in austere, remote environments is the ability to pack and carry enough food to sustain their operational and nutritional needs. To address this challenge and meet Army modernization requirements, US Army ration developers are developing a new ration to provide a lightweight, low volume, energy dense daily combat assault ration. The ration will use novel food processing techniques that remove air and water to reduce volume and increase physical density (g/cc) and will provide a high relative fat content to increase energy density (kcal/g or kcal/cc). As individuals tend to eat a constant weight or volume of food, manipulating physical and energy densities generally results in changes in energy intake without affecting subjective appetite sensations. However, relatively few studies have studied the independent effects on appetite and energy intake of increasing physical and energy densities of foods to the extent being targeted by the new ration, and none has directly studied the interaction between physical and energy density manipulation. This study will address that gap by determining the effects of foods that systematically vary in physical and energy density on ad libitum energy intake and subjective appetite ratings. Secondary outcomes will include gastrointestinal discomfort, fatigue and acceptability. Using a randomized, crossover design consisting of four separate phases, 20 participants will be provided with a standard base diet and experimental foods in which physical and energy density are systematically varied using different levels of mechanical compression and aeration, and different proportions of fat and carbohydrate, respectively. Consumption of the experimental foods at each of the physical and energy density combinations will be compulsory for 1 day while intake of the standard diet will be ad libitum. Total energy and macronutrient intake will be measured by collecting uneaten food items. Additionally, perceived appetite, gastrointestinal symptoms, fatigue and acceptability of the experimental food products will be measured by questionnaire.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Natick, Massachusetts, United States, 01760
        • US Army Research Institute of Environmental Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 35 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body mass index (BMI) ≤ 30.0 kg/m2
  • Willing to abstain from alcohol for 24 hours prior to and during days 1-2 of each study phase.
  • Willing to abstain from strenuous exercise for 24 hours prior to and during days 1-2 of each study phase.
  • Willing to abstain from a vegetarian/vegan diet or other highly restrictive diet (e.g., ketogenic diet, very high protein diet, Paleo diet) for two weeks prior to and throughout the study.
  • Willing to maintain body weight throughout study.
  • Willing to maintain usual diet (if not a restrictive diet), physical activity (aside from strenuous exercise limitation for 24 hours prior to and days 1-2 of each study phase) and nicotine use throughout study.
  • Willing to abstain from dietary supplements (e.g., metabolism boosters, appetite suppressants, weight loss aids) impacting appetite or metabolism (as determined by study PI) throughout the study.
  • Eats 3 meals per day at least 5 days/wk

Exclusion Criteria:

  • Pregnant or lactating.
  • Taking prescription medications, other than a contraceptive, known to affect appetite, digestion and/or metabolism (e.g., anti-diabetic agents) (unless approved by study PI)
  • Any chronic medical condition that limits food intake or alters metabolism, appetite or digestive physiology (e.g., gastric bypass, gastrointestinal disease, dysphagia, diabetes).
  • Allergies and intolerances (e.g. gluten, dairy, nuts), unwillingness or inability to eat provided foods and beverages.
  • Score of ≥13 on the restraint scale or ≥9 on the disinhibition scale of the Eating Inventory
  • Weight gain or loss of >5 lbs in the 2 weeks prior to study participation.
  • Not willing or unable to adhere to all study procedures and restrictions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low physical and energy density
Low physical density (LPD) + low energy density (LED) foods. Participants receive breakfast, lunch and snack items engineered to have LPD and LED.
Experimental: High physical and low energy density
High physical density (HPD) + low energy density (LED) foods. Participants receive breakfast, lunch and snack items engineered to have HPD and LED.
Experimental: Low physical and high energy density
Low physical density (LPD) + high energy density (HED) foods. Participants receive breakfast, lunch and snack items engineered to have LPD and HED.
Experimental: High physical and energy density
High physical density (HPD) + high energy density (HED) foods. Participants receive breakfast, lunch and snack items engineered to have HPD and HED.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total energy intake
Time Frame: Day 1 of each study arm.
Total energy intake from provided diet measured by weighing provided and uneaten foods.
Day 1 of each study arm.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Carbohydrate intake
Time Frame: Days 1 and 2 of each study arm
Total carbohydrate intake from provided and self-selected diet measured by weighing provided and uneaten foods, and food records.
Days 1 and 2 of each study arm
Protein intake
Time Frame: Days 1 and 2 of each study arm
Total protein intake from provided and self-selected diet measured by weighing provided and uneaten foods, and food records.
Days 1 and 2 of each study arm
Fat intake
Time Frame: Days 1 and 2 of each study arm
Total fat intake from provided and self-selected diet measured by weighing provided and uneaten foods, and food records.
Days 1 and 2 of each study arm
Self reported energy intake
Time Frame: Day 2 of each study arm
Energy intake from self-selected diet measured by food records.
Day 2 of each study arm
Appetite
Time Frame: Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
Hunger, fullness, desire to eat and prospective consumption measured by 100mm visual analog scale. Range is 0 to 100, with higher scores indicating greater hunger/fullness/desire/prospective consumption.
Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
Fatigue
Time Frame: Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
Level of fatigue measured by integer scale ranging from 0 (not tired) to 10 (total exhaustion)
Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
Gastrointestinal symptoms
Time Frame: Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
Heartburn, bloating, abdominal pain, urge to vomit, nausea, gas, urge to defecate, overall gastrointestinal discomfort measured by 100mm visual analog scale. Range 0 (none) to 100 (extremely severe).
Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
Acceptability
Time Frame: At breakfast, lunch and afternoon snack on day 1 of each study arm
Appearance, odor, flavor, texture, and overall acceptability of experimental foods rated on scale ranging from 1 (dislike extremely) to 9 (like extremely).
At breakfast, lunch and afternoon snack on day 1 of each study arm

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: J. Philip Karl, US Army Research Institute of Environmental Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 5, 2022

Primary Completion (Actual)

May 4, 2023

Study Completion (Actual)

May 4, 2023

Study Registration Dates

First Submitted

May 24, 2022

First Submitted That Met QC Criteria

June 1, 2022

First Posted (Actual)

June 7, 2022

Study Record Updates

Last Update Posted (Actual)

August 24, 2023

Last Update Submitted That Met QC Criteria

August 21, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 22-03HC
  • M-10975 (Other Identifier: US Army Medical Research and Development Command IRB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe